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Abstract
Structural studies of Alzheimer’s amyloid fibrils have revealed information about the structure at different levels. The
amyloid-L peptide has been examined in various solvents and conditions and this has led to a model by which a
conformational switching occurs from K-helix or random coil, to a L-sheet structure. Amyloid fibril assembly proceeds by a
nucleation dependent pathway leading to elongation of the fibrils. Along this pathway small oligomeric intermediates and
short fibrillar structures (protofibrils) have been observed. In cross-section the fibril appears to be composed of several
subfibrils or protofilaments. Each of these protofilaments is composed of L-sheet structure in which hydrogen bonding
occurs along the length of the fibre and the L-strands run perpendicular to the fibre axis. This hierarchy of structure is
discussed in this review. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Alzheimer’s disease is characterised by the deposi-
tion of insoluble amyloid ¢brils as amyloid plaques
in the neuropil as well as the accumulation of neuro-
¢brillary tangles in cell bodies of neurones [1]. The
amyloid ¢brils are composed of the amyloid-L pep-
tide (AL), a 39^43 amino acid residue peptide pro-
duced by cleavage from a larger amyloid precursor
protein, APP. The AL peptide is known to be present
in una¡ected individuals and is thought to have a
normal physiological role. However, in Alzheimer’s
disease patients the AL peptide forms ordered aggre-
gates which are deposited extracellularly as amyloid
plaques or senile plaques in the neuropil, and as vas-
cular deposits.
Alzheimer’s disease is not the only disease in which
amyloid ¢brils are involved in the pathology. There
is now a list of some 16 proteins which can form
amyloid ¢brils in various diseases [2,3]. These pro-
teins vary considerably in their primary structure,
function, size and tertiary structure, and yet they
appear to form amyloid ¢brils which show very few
structural di¡erences. Electron microscopy has
shown [4,5] that amyloid ¢brils are straight, un-
branching ¢bres of 70^120 Aî in diameter and of in-
determinate length. An electron micrograph of AL1^
40 amyloid ¢brils formed in vitro is shown in Fig. 1.
All amyloid ¢brils stain with the dye Congo red and
give a green birefringence when examined under
cross-polarised light, and ¢nally they reveal a cross-
L ¢bre di¡raction pattern which suggests a L-sheet
type structure for the ¢brils [3,6]. The nature of the
di¡raction pattern and its interpretation are illus-
trated in Fig. 2.
Structural studies of amyloid ¢brils from Alzheim-
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er’s disease brain have proved extremely di⁄cult due
to the insolubility of the plaques. Examination of the
structure of amyloid has concentrated on amyloid
¢brils formed in vitro from synthetic peptides homol-
ogous to the AL peptide. Peptide fragments of AL
form amyloid ¢brils in vitro which have a similar, if
not identical, morphology [7^11] and immunoreactiv-
ity to in situ Alzheimer’s disease amyloid [7]. How-
ever, even synthetic amyloid ¢brils are problematic
to study using conventional structural techniques.
Methods such as single crystal X-ray crystallography
and solution nuclear magnetic resonance (NMR)
cannot be used on ¢brils since they are insoluble.
Therefore X-ray ¢bre di¡raction, electron microsco-
py (EM), solid state NMR, Fourier transform infra-
red spectroscopy (FTIR) and circular dichroism
(CD) have been used to examine amyloid structure.
These techniques have yielded considerable informa-
tion about the morphology of amyloid ¢brils and
their internal structural conformation. However, we
have yet to obtain an unambiguous structure of the
amyloid ¢bril. In this review I will endeavour to dis-
cuss all the work that has led to a picture of amyloid
¢bril as it now stands.
The ¢eld of structural studies of AL amyloid is
extremely complex and encompasses the structure
of the soluble AL peptide, its polymerisation into
intermediates and from intermediates to amyloid ¢-
brils, to the ¢brils themselves and ¢nally to amyloid
deposition in vivo. Structural studies of soluble AL
Fig. 1. Electron micrograph of amyloid ¢brils formed in water
from AL1^42, stained with 0.1% phosphotungstic acid (Serpell,
unpublished results) showing long straight ¢brils of 70^80 Aî di-
ameter as well as ¢brillar aggregate background. Bar = 1000 Aî .
Fig. 2. This shows the characteristic cross-L spacings from X-ray ¢bre di¡raction from amyloid ¢brils. A strong 4.8 Aî re£ection on
the meridian corresponds to the hydrogen bonding distance between L-strands (shown right), and a more di¡use 10^11 Aî re£ection
on the equator shows the intersheet distance of about 10.7 Aî . A spacing of 9.6 Aî would correspond to the repeat distance for an
anti-parallel arrangement of L-strands. This is not always observed in poorly aligned di¡raction patterns, but often in well aligned pat-
terns [34].
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have concentrated on using NMR, CD and FTIR
methods to look at the structure of di¡erent regions
of AL in various solvents. Atomic force microscopy
(AFM) has proved a valuable tool to investigate the
nature of the intermediates in the amyloid pathway.
Transmission EM and ¢bre di¡raction have been
used to examine the structure of the amyloid ¢brils,
as well as methods of solid state NMR and FTIR.
Fascinating work on the amyloid plaques themselves
using optical microscopy reveals much about how
the ¢brils must assemble in vivo. Here I will concen-
trate on the structural aspects of amyloid ¢bril as-
sembly and deposition. Although there is much to
learn about amyloid structure from studies of other
amyloid diseases, this review will only touch on those
studies (see [2,12]).
2. The structure of soluble AL
Structure prediction studies [13] have indicated
that the C-terminal 10 residues and residues 17^21
of AL show the greatest hydrophobicity while the
C-terminus (from residue 28) showed a high proba-
bility for L-sheet structure. Residues 9^21 showed a
lower probability for L-sheet. Two L-turns are pre-
dicted between residues 6 and 8, and residues 23 and
27 [13,14]. These characteristics are highlighted in
Fig. 3.
The structure of the AL peptide has been exten-
sively studied in solution, although it is necessary to
use organic solvents such as DMSO and TFE, and
detergents such as SDS to keep AL soluble. The re-
sults of many experiments on various length frag-
ments homologous to AL are summarised in Table
1. NMR, CD and FTIR studies have shown that AL
generally forms K-helical conformation in organic
solvents [15,16,18^20,22,23,25,29,31^33,35] whereas
in aqueous bu¡ers or in water it is predominantly
L-sheet, although this can be a¡ected by pH, concen-
tration and incubation time [9,11,36]. Detailed NMR
studies of AL1^40 in ‘membrane mimicking’ solvents
have revealed the existence of helices between resi-
dues 15 and 36 [31] or 35 [33], with a ‘kink’ at res-
idues 25^27 [31] or loop at 24^30 [33]. Another study
showed AL1^40 and 1^42 containing helices at 10^24
and 28^42 [35]. The di¡erence in these results can be
attributed to di¡erences in pH and solvent (see Table
1). Similar studies on shorter peptides also show dis-
ordered residues at 25^27 [19,20,23].
3. Conformational switching
AL L-sheet content is linked to insolubility [10] and
related to neurotoxicity [9]. The ¢brillar state has
also been shown to be associated with protease resis-
tance [38]. It is thought that the AL peptide under-
goes a conformation switch from K-helical to L-sheet
structure during amyloidogenesis and that the struc-
tures of AL examined in organic ‘membrane mimick-
ing’ solvents resemble the structure of AL in vivo
[16,35]. Regions of the AL peptide responsible for
conformational switching and ¢brillogenesis have
been examined using solvents at various pHs to
look at the e¡ect of ionisation on side chains, amino
acid substitutions and truncation of AL from either
the N- or C-terminus.
The N-terminus is thought to be important for
initiating K^L conformational switching. An K-helix
in AL1^28 was shown to unfold with increasing tem-
perature and at mid-range pH and the hydrophobic
residues within 13^20 unfold under these conditions
[16]. A mechanism for the K-helix (monomer) to
L-sheet (oligomer) transition may involve the depro-
tonation of side chains Asp7, Glu11, Glu22 and
Asp23 above pH 4 and the protonation of His6, 13
and 14, causing a destabilisation of the K-helix [16].
Fig. 3. This ¢gure shows the results of structure prediction [13,14] which suggests regions with a high propensity for L-sheet structure,
shown in black. Clusters of hydrophobic residues are shown in magenta.
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Table 1
Region of AL Method Solvent and conditions Structure/conformation Reference
1^28 CD water (pH 1^4) random coil [15]
1^28 NMR TFE (pH 1^4) K-helix; increased temperature leads to decrease in helix,
13^20 remain most stable helix
[15,16]
1^28 CD water (pH 4^7) L-sheet [16]
1^28 NMR water (pH 5.6) not K-helical, extended strand [17]
1^28 NMR membrane mimic,
SDS and TFE
K-helix, bend at 12 [18]
1^28 and 1^28
(E22Q)
NMR DMSO C-terminal K-helix, N-terminal turn (£exible) [19]
1^28 EM, FD aqueous ¢brillar, cross-L [14]
1^28 (K16A) EM, FD aqueous amorphous, cross-L [14]
12^28 NMR SDS (pH 5.6) K-helix 16^24 [20]
x^28 (19^28, 17^28,
15^28, 13^28, 9^28)
FTIR, FD various pH (aqueous) L-sheet dependent on pH (most L-structure
at VpH 3^7);
19^28 showed low L and mostly random coil
[8]
10^23 FTIR solid state L-sheet (antiparallel) [11]
10^24 FTIR, CD unclear K-helix [13]
10^24 FTIR, CD unclear L-sheet [13]
10^35 ssNMR dried from water (pH 7.4) L-sheet (parallel) [21]
19^35, 25^35
(Met35 analogues)
CD various (aqueous, increased
pH; ACN; TFE)
increased L-sheet structure with time from random coil ;
K-helix in TFE
[22]
25^35 NMR LiDS and TFE (pH 4) K-helix 28^34, disordered 25^27 [23]
25^35 CD aqueous (pH 4, 5) L-sheets random coil (decreased concentration) [24]
(pH 5.5) L-sheet
(pH 7.4) L-sheet
25^35 CD, FTIR TFE L-sheet [25]
26^33 FTIR water random coil or K-helix [10]
29^42 FTIR solid state L-sheet (antiparallel) [11]
29^42 CD aqueous (pH 7.4) L-sheet [11]
34^42 ssNMR aqueous L-sheet (antiparallel) [26]
34^42 FTIR water L-sheet [26]
1^39 CD aqueous (pH 7.3) random coil and L-sheet [15]
1^39 CD TFE (30%) (pH 1^4, 7^10) K-helix [15]
1^39 FTIR DMSO (100%) no L-sheet content [27]
1^39 CD aqueous (pH 7.4) L-sheet (V60%) [27]
1^39 CD TFA (0.1%) (pH 7.4) L-sheet (V30%) [28]
1^39 CD ACN (35%)/TFA (0.1%) L-sheet (V60%) [28]
1^40 FTIR aqueous (pH 7.5) ‘1% K, 60% L’, mostly L-sheet [29]
1^40 CD TFE (20%) (pH 7.4) ‘16%’ K-helix [29]
1^40 (V18A) FTIR aqueous (pH 7.5) ‘33% K, 31% L’, K-helix and L-sheet [29]
1^40 (V18A) CD TFE (20%) (pH 7.4) ‘50% ’ K-helix [29]
1^40 (E22Q) CD TFE (20%) (pH 7.4) ‘6%’ K-helix [29]
1^40 CD aqueous (pH 7.8) L-sheet (V55%) [30]
1^40 NMR SDS (pH 5.1) K-helix 15^36, kink 25^27 [31]
1^40 Met35Ox NMR SDS (pH 5.3) K-helix 16^24 [32]
1^40 NMR TFE (40%) (pH 2.8) K-helix 15^23, 31^35 [33]
1^40 FD water cross-L [34]
1^42 CD water L-sheet [15]
1^42 CD TFE (30%) (pH 1^4, 7^10) K-helix [15]
1^40 and 1^42 NMR (SDS) (pH 7.2) K-helix 10^24 and 28^42 [35]
10^43 CD water ‘80%’ L-sheet [11]
10^43 CD HFIP ‘28%’ K-helix [11]
ex vivo FD water extracted cross-L [37]
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At a critical concentration, this may be accompanied
by rearrangement to an oligomeric L-sheet [16]. Fi-
bril formation studies of ALx^28 (see Table 1) in
various pH environments [8] revealed the importance
of electrostatic interactions involving His^Asp/Glu
salt bridges as well as hydrophobic contacts in the
region Leu17^Ala21 and a model is proposed by
which a central intersheet core of electrostatic and
hydrophobic interactions stabilises an anti-parallel
arrangement of L-strands de¢ned by residues 13^23
[8,14]. NMR analysis of AL12^28 in water identi¢ed
a central hydrophobic cluster at residues 17^21, but
did not ¢nd evidence for salt bridge interactions be-
tween His14 and Glu22 [39].
Introduction of a single amino acid substitution
(V18A) in AL1^40, which leads to an increased pro-
pensity for K-helical conformation compared to wild
type, was found to be related to a decreased ability
to form amyloid ¢brils [29]. Substitution of residues
Lys16 in AL1^28 [14] or Phe19 or 20 for Ala in
10^23 [11] results in peptides unable to form amy-
loid-like ¢brils in vitro. It has also been observed
that AL1^40 and AL1^42 with the Dutch-type amy-
loidosis mutation, Glu22Gln, show increased amy-
loid ¢bril formation and ¢bril stability compared to
wild type [9,40,41]. This results from a decrease in
electrostatic potential in the hydrophobic core region
of 17^21 causing an enhancement of interactions be-
tween uncharged side chains [9].
Extensive studies of AL43 [11] and fragments of
this peptide revealed that region 10^42 may form
the L-sheet core of the amyloid ¢brils, whereas resi-
dues 1^9 may be exposed on the surface of the ¢bres
and be involved in interaction between ¢brils. Trun-
cated peptides from the AL N-terminus showed that
residues 1^9 were not necessary for ¢bril formation
[11]. The presence of a L-turn was mapped to resi-
dues 26^29 by protease digestion of various inter-
nally cross-linked peptides with engineered disul¢des,
and the £anking regions were proposed to form two
L-strands. Fragments of 10^23 and 29^42 were both
found to form L-sheet structure by FTIR, but 29^42
was less soluble and formed only very short ¢brils,
whereas 10^23 formed long ¢brils. Recently, Nor-
stedt and co-workers [42] showed that the smallest
region of the N-terminus of AL capable of forming
amyloid ¢brils was residues 14^23, and that deletions
or substitutions in this region result in the loss of
¢bril forming ability, suggesting that this sequence
forms the core of AL ¢brils.
4. Structure of AL ¢bril intermediates
Beta-sheet conformation is tightly linked to ¢bril-
logenesis [43]. The kinetics of amyloid ¢bril assembly
have been well studied and are discussed by Roher in
this edition. It is thought that ¢bril formation pro-
ceeds via a nucleation dependent mechanism which is
highly concentration dependent and that this pro-
ceeds via a partially folded intermediate [43]. Puri¢-
cation of AL1^42 peptide from Alzheimer’s disease
brain yielded stable dimeric and trimeric forms, and
monomers which were then capable of forming ¢brils
in vitro [44]. Fluorescence spectroscopy and £uores-
cence resonance energy transfer of AL1^40 have
shown that it is capable of existing as a stable dimer
in aqueous solutions [45].
Examination of amyloid ¢bril formation from var-
ious synthetic peptides has revealed the presence of
an intermediate in the pathway that has been visual-
ised by EM, sedimentation and AFM. The ¢rst stage
can be described as ‘seeds’ and these are usually de-
scribed as being spherical or globular in appearance
[46,47]. Sedimentation analyses identi¢ed aggregates
of 50 000 S (around 1010 Da) andV30 S (around 106
Da) [48] and quasi-elastic light scattering (QLS) stud-
ies suggest that these may be represented by ‘mi-
celles’ of AL [49] which have an estimated diameter
of 140 Aî . AFM in situ has suggested that the glob-
ular particles associate over time [47] and following
¢bril formation using QLS has inferred that mono-
mers associated to form micelles from which ¢brils
nucleate and then elongate [49]. Studies of the short
AL14^23 peptide suggest that ¢bril polymerisation
[42] proceeds via the formation of dimers, then tet-
ramers and ¢nally oligomers, in which the charged
residues form ion pairs and the hydrophobic residues
form a hydrophobic core. This pathway for ¢brillo-
genesis is supported by results from other groups for
AL1^40 and 1^42 [50,51]. Although the structure of
the intermediate is unknown, a theoretical model has
been suggested based on the fact that AL1^42 shows
some sequence homology to the enzymes catalase
and triosephosphate isomerase. Both proteins are in
an anti-parallel L-sheet conformation [52] and mod-
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elling studies of AL have led to a proposed Greek
key motif which dimerises to form a L-barrel ar-
rangement exhibiting a hydrophobic core and a hy-
drophilic surface [52].
5. From ‘proto¢brils’ to ¢brils
‘Proto¢brils’ have been described by a number of
investigators [50,51,53]. These appear to be precur-
sors to full-length ¢brils, which have a curved ap-
pearance and are generally shorter than fully formed
¢brils. Negative stain EM of proto¢brils formed
from AL1^40 and 1^42 show £exible ¢bres around
60^100 Aî in diameter [53].
AFM has recently revealed more detailed informa-
tion about the process of aggregation of the AL pep-
tide. Small ordered aggregates or ‘proto¢brils’
(V30 Aî diameter by 200^700 Aî ) were clearly ob-
served at the early stages of ¢bril formation for
both AL1^42 and AL1^40 [50]. These elongated
with time and showed a beaded appearance and a
periodic repeat of V220 Aî . The proto¢brils were
closely followed by the appearance of longer ¢brils
of two di¡erent morphologies. ‘Type 1’ ¢brils were
around twice the diameter of the proto¢brils (V70^
80 Aî ) and showed a periodic twist every V430 Aî .
Type 2 ¢brils generally appeared later and were
around 38^45 Aî in diameter and did not show an
obvious periodicity. AL42 ¢brils formed more rap-
idly than AL40 ¢brils. Stine et al. [53] also report
the appearance of both smooth and periodic twisted
¢brils of AL1^40 by AFM with thicknesses of about
40^60 Aî or 80^120 Aî respectively. They describe a
periodicity of around 250 Aî . Small proto¢brils with
an estimated diameter of 20^30 Aî were also ob-
served.
In situ AFM of AL1^42 aggregation upon hydro-
philic mica or hydrophobic graphite has allowed the
time course of ¢bril formation to be followed in
phosphate-bu¡ered saline [47] and shows a marked
di¡erence between the behaviour of AL on the two
di¡erent environments. Small globular aggregates
(V50^60 Aî height) were observed on the hydrophilic
support, which tended to coalesce slowly over time,
whereas on the hydrophobic support, AL aggregated
to form narrow elongated sheets, which appeared to
orient into parallel assemblies in line with the carbon
atoms of the graphite support. The average lateral
spacing was around 180 Aî with a height of V10^
12 Aî , suggesting the formation of a single L-sheet
which interacts with the hydrophobic surface. These
data point to the importance of hydrophobic inter-
actions between the L-sheets in amyloid ¢brils.
6. Composition of ¢brils ^ proto¢laments
Cross-sections of synthetic AL amyloid ¢brils (res-
idues 11^28, 1^28 [8,14], 6^25 [7]) have been viewed
by taking thin sections of embedded ¢brils and ex-
amining them under the electron microscope. They
appear to be composed of ¢ve or six proto¢laments
arranged around a ‘hollow’ centre, each proto¢la-
ment having a diameter of around 25^30 Aî . Inter-
pretation of X-ray di¡raction patterns from aligned
¢brils of AL has also led to the conclusion that the
¢brils are composed of ¢ve or six proto¢laments (or
sub¢brils) [54]. The details of this are discussed in
Section 7. Amyloid ¢brils from other disease states
have been examined by EM and these also suggest a
packing of several proto¢laments making up the
amyloid ¢bril [4,55].
7. Beta-sheet structure of amyloid ¢bril proto¢laments
Fibre di¡raction and solid state NMR have re-
vealed much about how the L-sheets are arranged
within the amyloid ¢bril proto¢lament. Fibre di¡rac-
tion data show only the repeating structure within a
molecule. Beta-sheet structure along the ¢bre axis is
shown up by the intense 4.7^8 Aî re£ection, since the
hydrogen bonding of L-strands up the ¢bres extends
in¢nitely. The length of the hydrogen bonds does not
vary since it is sequence independent. Solid state
NMR is capable of measuring interactions over rel-
atively short ranges (V6 Aî ), and therefore contrib-
utes information about the local interactions within
the L-sheets. Both these methods describe the struc-
ture within the proto¢lament, although some limited
information about proto¢lament packing can be re-
vealed by ¢bre di¡raction.
Fibre di¡raction studies of ex vivo AL amyloid
¢brils from Alzheimer’s plaques showed an unor-
iented cross-L pattern with rings at 4.74 Aî and 10^
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11 Aî which indicates a L-structure with the strands
running perpendicular to the ¢bre axis [37]. This dif-
fraction pattern has also been observed from various
ex vivo amyloid ¢brils [3], suggesting that amyloid
¢brils composed of di¡erent proteins may share a
common core structure. A structural model of the
transthyretin amyloid ¢bril proto¢lament has been
described as a L-sheet helix type structure with four
L-sheets composed of L-strands running perpendicu-
lar to the ¢bre axis and turning around a central axis
with a twist of 15‡ between one L-strand and its
hydrogen bonded neighbour [56]. Improvement of
the alignment of the amyloid ¢brils by incubating
synthetic AL peptides in a magnetic ¢eld revealed
highly aligned di¡raction patterns [54]. This method
appears to work well for the orientation of smaller
peptides which form amyloid ¢brils whilst in the
magnetic ¢eld, but less well for full-length AL pep-
tides [34,54] or for ex vivo amyloid ¢brils (Serpell,
Sunde, Fraser, unpublished results). Fig. 4 shows
X-ray ¢bre di¡raction patterns from partially aligned
AL1^40 ¢brils and magnetically aligned AL11^25.
A model of the Alzheimer’s amyloid ¢bre has been
suggested from ¢bre di¡raction of magnetically ori-
ented samples and EM of AL1^40 [34]. Negative
stain EM indicated that AL1^40 forms a mixture of
twisted ¢bres (60^90 Aî diameter and 460 Aî pitch)
and straight ¢bres (60^80 Aî diameter). Thin sections
of the ¢brils suggested that they were composed of
several proto¢laments arranged around an electron
lucent centre and the ¢bre di¡raction pattern showed
the characteristic cross-L pattern consisting of a
sharp 4.7 Aî meridional re£ection and a broad re£ec-
tion centred at 9 Aî on the equator. The di¡raction
pattern also revealed lower angle re£ections on the
equator at 49.2 Aî , 19 Aî and 13.7 Aî . The ¢bre pat-
tern was interpreted to have arisen from a structure
in which pairs of L-sheets (with a spacing of 9 Aî
between them) form a tubular cylinder of diameter
V28 Aî , this comprises one proto¢lament, and be-
tween three and ¢ve proto¢laments make up the
V70 Aî ¢bril. It is suggested that the L-strands do
not run perpendicular to the ¢bre axis as is generally
interpreted from cross-L patterns [57,58], but that the
strands are tilted by 35.6‡ [9,34]. This is inferred
from a previous AL40 di¡raction pattern [9] in which
re£ections at 4.7 Aî and at 3.84 Aî are both o¡ meri-
dional. However, Malinchik et al. [34] show that
both re£ections are meridional in their more recent
AL40 pattern and attribute this to cylindrical averag-
ing (see [59]). In previous ¢bre di¡raction analyses of
several di¡erent amyloid ¢brils [3,56] the 3.84 Aî o¡-
meridional re£ection was also noted and was attrib-
uted to the spacing between CK in a pleated L-sheet
being arranged in a helical manner. A further weak
meridional spacing at around 54 Aî [7], 53 Aî [54] or
57 Aî [9] on the AL1^40 di¡raction pattern has been
suggested to correspond to an axially repeating unit
Fig. 4. X-ray ¢bre di¡raction patterns of (a) a partially aligned sample of AL1^40 amyloid ¢brils and (b) a magnetically aligned sam-
ple of AL11^25 amyloid ¢brils. The small arrow shows 10^11 Aî re£ection on the equator and the arrowhead shows the strong 4.8 Aî
re£ection on the meridian in both (a) and (b) (Serpell, unpublished).
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consisting of V12 hydrogen bonded L-strands (i.e.
half number suggested for TTR [56]), but could also
arise from a helical twist.
In a previous publication Kirschner and colleagues
[54] presented an extensive library of ¢bre di¡raction
patterns from di¡erent length peptides of AL. The
¢brils were aligned in a magnetic ¢eld and produced
well-oriented di¡raction patterns. The di¡raction
patterns could be separated into three groups.
The ¢rst group (residues 19^28, 13^28, 12^28, 11^
28, 9^28, 1^28, 1^38, 1^40, 6^25, 11^25 and 34^42)
exhibited patterns showing the characteristic cross-L
re£ections (see Fig. 4b). Some of these patterns were
analysed and were assigned a monoclinic spacegroup
and a cell of a = 9.44 Aî (hydrogen bonding direc-
tion), b = 6.92 Aî (polypeptide chain direction),
c = 10.76 Aî (intersheet spacing) which would contain
two amino acid residues in a pleated-L conformation
(see Fig. 5). Di¡raction patterns from AL6^25 and
AL11^28 showed sampling of Bragg re£ections along
layer lines suggesting a highly organised packing of
¢bres within the sample. Modelling of a possible
structure of L-crystallites was attempted using phases
from the structure of L-keratin (which is incidentally
extended-L with strands running along the ¢bre axis,
not cross-L [60]). The equatorial re£ections were
found to index to a one-dimensional lattice (V 60
Aî ). This could be explained by either a cylindrical
lattice or a restricted crystalline lattice. However, the
model interpreted to best ¢t the AL11^28 data was a
hollow cylinder or tube composed of ¢ve L-crystal-
lites, each 20 Aî by 50 Aî . These were arranged in a
pentamer with centres exactly positioned at lattice
points. The crystallites (or ‘sub¢brils’ = proto¢la-
Fig. 5. This shows the arrangement of an anti-parallel L-sheet in which a hydrogen bonding distance of 4.8 Aî , a sheet spacing of 10^
11 Aî and a repeat distance along the polypeptide chain of 6.9 Aî are apparent.
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ments) were thought to be made up of approximately
¢ve L-sheets (each with a spacing of 10 Aî between
them) and around six residues (three lattice points,
6.9 Aî between every other CK) along the polypeptide
chain.
A second group (18^28, 17^28, 15^28) were
thought to arise from a plate-like arrangement of
L-sheets with the rotation axis parallel to the poly-
peptide chain. These structures were extended in
both the hydrogen bonding and intersheet directions.
The loss of His13 and His14 from these peptides as
compared to many of those in group A may account
for the di¡erence in forming tubular or plate-like
structures [54], suggesting that the histidines weaken,
rather than strengthen the intersheet interactions
(however, this is not clear cut, since 19^28 is in group
A).
Finally, the third group (22^35, 26^33) resulted in
¢bre di¡raction patterns with no alignment, likely to
be due to disorientation of the L-crystallites.
The authors suggest that the hydrophobic residues
Leu17-Val18-Phe19-Phe20 and Ala21 form the core
interactions in the intersheet direction and that re-
maining ionic residues may be involved in interaction
between ‘sub¢brils’ or proto¢laments.
This publication concentrated predominantly on
the intersheet direction and did not discuss the hy-
drogen bonding direction. Whether or not these data
indicate parallel or anti-parallel arrangement of
L-strands is unclear [54]. The presence of a layer
line at 9.4 Aî is suggestive of an anti-parallel arrange-
ment of L-strands, since this spacing would corre-
spond to every other L-strand which would be the
true repeat. However the re£ection corresponding to
the L-strand spacing 4.7 Aî is by far the strongest in
these di¡raction patterns (see Fig. 4).
The structure of amyloid ¢brils formed from
AL10^35 has been studied using solid state NMR
[21]. 13C were positioned at Gln15 and Lys16, be-
cause of previously published results of cross-linking
studies using transglutaminase which showed that
Gln15 from one peptide and Lys16 from the next
are adjacent in the amyloid ¢bril [61^65]. In AL10^
35 13C Gln15, a distance measured between the 13C
from adjacent peptides was 5.1 Aî ( þ 0.2), and for
AL10^35 1-13C Lys16 4.9 Aî ( þ 0.2). These distances
of around 5 Aî could ¢t models of anti-parallel and
parallel L-structure. However, the NMR data can be
explained by a model in which every 13C carbonyl
interacts with two, equidistant 13C carbonyls and
these data are best ¢tted by a parallel arrangement
in which the residues are in exact register. This in-
terpretation was further validated by the measure-
ment of 5.0 Aî spacings for two new peptides con-
taining 13C carbonyls at residues 17 and 18, which
can be most clearly explained by a parallel arrange-
ment, since no interaction would be detected for an
anti-parallel arrangement. However, this model is
di⁄cult to ¢t to previously observed characteristics.
FTIR measurements have consistently referred to
anti-parallel structure for AL amyloid [10,11]. Fibre
di¡raction studies of ¢brils formed from various
fragments of AL have found layer lines correspond-
ing to a 9.6 Aî repeating unit [7^9,34,54] which is
thought to arise from an anti-parallel arrangement
with the repeat being every other L-strand. Benzinger
et al. [21] do not account for the rest of the AL10^35
in their model of the parallel L-strand arrangement
(only the six residues 13^18) and it is di⁄cult to
understand how the remaining structure would fold
into a L-sheet without allowing for L-hairpin forma-
tion and therefore anti-parallel L-sheet conformation.
If L-strands were in an extended L-strand conforma-
tion then they would measure around 6.95 Aî
[66]U42/2 = 146 Aî for AL1^42 and 139 Aî for
AL40, which is larger than the 40^80 Aî measurement
of ¢brils formed in vitro [14,50,53]. A structural
model of amyloid ¢brils formed from AL34^42 [26]
using solid state NMR rejected the possibility of
L-hairpins making up the structure based on search-
ing a library of conformations against the data. They
suggest that the ¢brils were made up of extended
L-strands in an anti-parallel arrangement. One pos-
sibility for a parallel L-sheet arrangement is sug-
gested by a L-helix type structure [67^72]. This type
of structure has been suggested for amyloid by Lazo
and Downing [73], although more rigorous model
building and measurements of spacings are necessary
to ensure that the model will ¢t with experimental
data [3,14,37] before any conclusions can be drawn
about the validity of this theoretical model. Another
possibility could be an arrangement with a mixture
of parallel and anti-parallel L-hairpins as shown in
Fig. 6.
A study by O’Chaney et al. [52] suggested a theo-
retical three-dimensional model of the AL1^42 amy-
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loid ¢bril. This was built from tetrameric building
blocks consisting of two ‘L-barrel’ dimers with
C-terminal domain (residues 30^42) extended to
form an anti-parallel L-sheet [52]. These were then
further dimerised to form an octamer consisting of
hydrophobic twisted L-sheet (C-terminal domains of
AL1^42 monomers) £anked by a series of adjacent L-
barrels arranged helically around the sheet. This
model is proposed to comprise the proto¢lament (di-
ameter V65 Aî ). It was then suggested that three of
these proto¢laments intertwine to form the ¢bril (di-
ameter V120 Aî ) forming structure which appears to
be composed of six globular units (three dimers) in
cross-section [52].
8. Amyloid ¢bril deposition and structure of the
plaques in Alzheimer’s disease
Amyloid ¢brils are deposited in neuritic plaques
extracellularly in the cortex of Alzheimer’s disease
brains. The central deposit of amyloid ¢brils (the
core) is surrounded by dystrophic neurites, activated
microglia and reactive astrocytes.
Studies of the morphological structure of the senile
plaque using optical microscopy [74] have revealed
that they typically consist of a porous core with char-
acteristic pore sizes and a di¡use ring from which the
density decays from the centre of mass of the core.
The authors propose that this pattern of structure
could be produced from a process whereby aggrega-
tion occurs simultaneously with disaggregation thus
producing a porous structure. This model would ex-
plain the observation that the amount of AL depos-
ited in patients varies only slightly and does not in-
crease with disease progression, but remains
relatively constant [74].
The molecular structure of the plaques has been
studied in situ using FTIR microspectroscopy meth-
ods [75], and this has shown that the core of the
plaques gives a strong L-sheet conformation signal
compared to an K-helical or random signal from
surrounding areas of grey matter. The observation
of L-sheet is consistent with results from biophysical
methods from ex vivo and synthetic amyloid [14,
37].
9. Alzheimer’s disease amyloid associated molecules
In vivo the concentration of AL is much less than
is used in ¢bril formation in vitro. It is thought that
other proteins and molecules play an important role
in amyloid ¢bril formation and deposition. These
Fig. 6. Four possible arrangements for a short L-strand (e.g. 10^35 [21], 34^42 [26]. (a) anti-parallel L-hairpin arrangement; (b) theo-
retical anti-parallel L-hairpins arranged parallel to one another; (c and d) extended L-strands in anti-parallel (c) and parallel (d) ar-
rangements.
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will be mentioned brie£y. They include the glycos-
aminoglycan (GAG), heparan sulfate proteoglycan
(HSPG) [76], serum amyloid P (SAP) [77], apolipo-
protein E (Apo E) [78,79], K1-antichymotrypsin
(ACT) [80] and complement factors (C1q, C3d and
C4d [81]).
HSPG is associated with amyloid ¢brils in all amy-
loid diseases and is thought to play an important role
in amyloid deposition. GAGs can increase ¢bril for-
mation and lateral aggregation of AL peptides in
vitro [82]. The binding is thought to occur via sulfate
groups, since addition of sulfate ions to peptides in
vitro appears to show a similar e¡ect. Fibre di¡rac-
tion patterns of synthetic amyloid ¢brils suggest a
periodicity of 65 Aî for sulfate binding along the ¢bre
axis [82]. The e¡ect of GAGs on ¢bril formation
appears to be pH dependent [83] so the interaction
of GAGs with amyloid proteins is thought to be via
electrostatic interactions and in the case of AL is
probably mediated by His13 and His14 [82].
SAP is also found in all amyloid deposits [77] and
binds to them in a calcium dependent manner [84]. It
is a member of the pentraxin family of proteins and
exists as a decamer with two pentameric rings ar-
ranged face to face. Each subunit displays a jelly-
roll fold of highly L-sheet structure [85]. SAP is
highly protease resistant in the presence of calcium
and is thought to have a role in protecting amyloid
¢brils against degradation [86,87].
Apo E has been linked to some cases of late onset
Alzheimer’s disease [78,88] and is present in senile
plaques. Unlike other amyloid associated proteins,
ACT is speci¢c to Alzheimer’s disease. It co-localises
with senile plaques and vascular amyloid during the
earliest stages of its development [80,89]. ACT is a
member of the serine protease inhibitor family (ser-
pins). Similarity between the AL residues Asp7-Ser8-
Gly9 and active sites of serine proteases has led to
the proposed ACT binding site [90]. ACT has been
shown to have an e¡ect on amyloid ¢bril formation
[90,91].
10. Conclusions
Structural studies of amyloid ¢brils are non-trivial.
They are extremely insoluble and stable and there-
fore very di⁄cult to work with by conventional
methods. AL research has concentrated on the use
of model peptides for structural studies, and this
Fig. 7. This ¢gure shows the hierarchy of structure from the AL peptide folded into a L-pleated sheet structure through proto¢laments
to amyloid ¢brils. Views shown looking down the axis of the ¢bre and axially.
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has led to an in-depth knowledge of the importance
of various regions of AL. However, the information
gathered from these studies is complex because of the
many di¡erent solvents and conditions used in di¡er-
ent studies of amyloid ¢bril structure and assembly.
In summary, studies of the AL peptide in various
‘membrane mimicking’ solvents had suggested K-hel-
ical conformation for the soluble AL peptide, whilst
¢brillogenesis of AL has been shown to be linked to
a conversion to L-sheet structure. Residues 11^16 are
thought to be important in forming electrostatic in-
teractions and residues 17^21 in hydrophobic inter-
actions. A short peptide 14^23 is capable of forming
amyloid ¢brils in vitro and the region 11^24 is
thought to play an important role in K to L conver-
sion. Residues 25^35 have been implicated in neuro-
toxicity and residues 34^42 are very hydrophobic and
are thought to be situated in the transmembrane re-
gion in APP. Peptides of this region are extremely
insoluble and have been implicated in nucleating
amyloid ¢bril formation.
Assembly of amyloid ¢brils appears to be a com-
plicated process which is still poorly understood.
Whilst it is clear that amyloid ¢brils are composed
of several proto¢laments (¢ve or six), the mechanism
of assembly and the exact morphology remain un-
clear. Proto¢brils have been identi¢ed which appear
to be ¢brillar precursors to amyloid ¢bril formation,
and these are preceded by the appearance of small
oligomers of AL. Whether these small intermediates
interact directly to form proto¢brils and then these
elongate to form the fully formed ¢bril, or whether
proto¢laments are formed ¢rst and then associate
together remains ambiguous. The hierarchy of struc-
tures within amyloid ¢brils are illustrated in Fig. 7.
The predominantly L-sheet structure of the proto-
¢laments seems to be generally accepted, with L-
strands running perpendicular to the ¢bre axis and
held together by hydrogen bonding. Whether these
are arranged parallel or anti-parallel is still under
dispute and how these L-sheets assemble into the
proto¢lament and then the ¢bril has been modelled,
but not proven. Developing techniques for directly
visualising amyloid ¢brils at high resolution, such
as cryo-electron microscopy with image processing
and AFM combined with X-ray di¡raction data
and solid state NMR, may hold the key to solving
the structure of the Alzheimer’s amyloid ¢bril.
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